Defining a high-risk subgroup of pathological T2N0 gastric cancer by prognostic risk stratification for adjuvant therapy.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Adjuvant therapy is not usually recommended in AJCC T2N0M0 gastric cancer, yet sometimes is indicated for high-risk patients. The purpose of this study is to stratify the risk of pathological T2N0 gastric cancer after gastrectomy based on clinicopathological factors so as to predict prognosis and guide treatment.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J. Gastrointest. Surg.

Title: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

Publisher: Springer Nature America, Inc

ISSN (Electronic): 1873-4626

ISSN (Print): 1091-255X

Publication date (Electronic): Dec 2011

Volume: 15

Issue: 12

Affiliations

[1 ] Department of Gastric Cancer and Soft Tissue Surgery, Cancer Center, Fudan University, Shanghai, People's Republic of China.

Article

DOI: 10.1007/s11605-011-1684-6

PubMed ID: 21938559

SO-VID: f9f8666e-448d-4087-bac8-b2ad161b293a

History

Data availability:

Comments

Comment on this article

scite_

0

Smart Citations

0

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Cited by 8

See all cited by